Latest news, press releases, and SEC filings for Royalty Pharma PLC (RPRX) https://caymanjournal.com/stock/RPRX en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 18:44:17 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is Royalty Pharma's **Annual Report to Shareholders (ARS)**. Think of it as the company's "year in review" magazine, packaged for investors. It’s not just a dry legal filing; it’s designed to tell the story of their past year, showcase their financial health, and expl https://caymanjournal.com/stock/RPRX/sec-filing/0001140361-26-014242 https://caymanjournal.com/stock/RPRX/sec-filing/0001140361-26-014242 Fri, 10 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **proxy statement** (DEF 14A) for Royalty Pharma's 2026 Annual General Meeting. Think of it as an information packet and voting guide for shareholders. It explains what will be voted on at the meeting, provides details about the company's leadership and pay, and https://caymanjournal.com/stock/RPRX/sec-filing/0001140361-26-014239 https://caymanjournal.com/stock/RPRX/sec-filing/0001140361-26-014239 Fri, 10 Apr 2026 00:00:00 GMT SEC Filing